An innovative immunoassay, called enzyme-linked immunoabsorbant assay (ELISA) Reverse, based on a new conformation of the solid phase, was developed. The solid support was expressly designed to be immersed directly in liquid samples to detect the presence of protein targets. Its application is proposed in those cases where a large number of samples have to be screened simultaneously or when the simultaneous detection of different proteins is required. As a first application, a quantitative immunoassay for Cry1AB protein in genetically modified maize was optimized. The method was tested using genetically modified organism concentrations from 0.1 to 2.0%. The limit of detection and limit of quantitation of the method were determined as 0.0056 and 0.0168 (expressed as the percentage of genetically modified organisms content), respectively. A qualitative multiplex assay to assess the presence of two genetically modified proteins simultaneously was also established for the case of the Cry1AB and the CP4EPSPS (5-enolpyruvylshikimate-3-phosphate synthase) present in genetically modified maize and soy, respectively.

Maize MON 810 is one of the European Union's (EU) authorized genetically modified organisms (GMO) for placing on the food and feed market. The total number of MON 810 varieties registered in the European Common Catalogue of varieties of agricultural plant species has almost tripled since 2005. One of the requirements described in EU legislation, namely the genetic stability of GM seed varieties, was thus assessed by analyzing the intactness of the entire MON 810 integration and its genotypic stability in commercial varieties available on the market for at least the last 2 years. A combined strategy using qualitative analytical methods made possible to determine the presence/absence of the individual genetic elements and of the whole GM construct. The restriction fragment length polymorphism patterns obtained from amplified whole constructs by long polymerase chain reaction (PCR) were compared side by side. CryIA(b) protein expression levels were determined by enzymelinked immunosorbent assay. Twenty-four out of the 26 analyzed varieties met the expected stability features. One variety gave negative results in all assays, and one variety contained the necessary genetic elements for expressing CryIA(b) protein although giving negative results for the long PCR product. To our knowledge, this study is the first post-marketing stability analysis performed on GM commercial seed varieties.

Real-time PCR (RTi-PCR) is the technique of choice for event-specific quantification of genetically modified organisms (GMOs) by determining the amount of event with respect to a species-specific reference gene. Reference genes can be amplified from the genome extracted from Certified Reference Materials (CRMs) or from ad hoc designed plasmids. In the present study, we statistically evaluate the performance of RTi-PCR protocols for GM maize MON810 event by using both genomic DNA from conventional CRMs and a plasmid containing sequences representative of four maize species-specific reference genes. The significance of simple and interaction effects of several variables included in the experimental design on DNA quantification methods and RTi-PCR were evaluated and discussed. Statistically significant differences on Ct values may have an impact on the GMOs quantification and consequently on the compliance of GM quantificationestablished legal thresholds. Our results confirm the reliability of the plasmid as alternative calibrant for the calculation of GMOs copy number.